Pin Zhang

A Nation-Wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in china

Jing Li, Bao‐Ning Zhang, Jin‐Hu Fan et al. · BMC Cancer · 2011 · 230 citations · Full text

Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Fei Ma, Qiao Li, Shanshan Chen et al. · Journal of Clinical Oncology · 2017 · 228 citations

Metastatic Breast Cancer, Oncology, Biomarker Analysis +12

A Critical Function of Th17 Proinflammatory Cells in the Development of Atherosclerotic Plaque in Mice

Qi Gao, Yang Jiang, Tian Ma et al. · The Journal of Immunology · 2010 · 217 citations · Full text

Immunology, Immune Regulation, Pathology +24

Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial

Binghe Xu, Qingyuan Zhang, Pin Zhang et al. · Nature Medicine · 2021 · 152 citations · Full text

Breast Oncology, Medicine, Pharmacology +7

In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China

Yiqun Li, Nilupai Abudureheiyimu, Hongnan Mo et al. · Frontiers in Oncology · 2022 · 118 citations · Full text